Jerome B. Zeldis

Insider Reports History

Identity 1 fact
Location
Scottsdale, AZ
SEC filing record 1 fact
SEC signature
/s/ Avraham S. Adler, Attorney-in-Fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jerome B. Zeldis

Form 4 holding Director

NEXGEL, INC.

Security class
Common Stock
Shares / value
106,664
Estimated value
$293,326
Report date
20 Nov 2024
Price
$2.75
Ownership
Direct
Form 4 holding Director

PTC THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
3,475
Estimated value
$238,040
Report date
02 Jan 2026
Price
$27.05
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive VP of Research & Dev

NexImmune, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
80,100
Estimated value
Report date
05 Apr 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NEXGEL, INC.

Security class
Stock Option (Right to Buy)
Shares / value
30,000
Estimated value
Report date
25 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

SOLIGENIX, INC.

Security class
Stock Option (Right to Buy)
Shares / value
17,647
Estimated value
Report date
20 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NEXGEL, INC.

Security class
Warrant to Purchase Common Stock
Shares / value
1,818
Estimated value
Report date
20 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jerome B. Zeldis

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .